Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin + Carvedilol for Cirrhotic Cardiomyopathy
NCT06431919Recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jun 2025
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of simvastatin in cirrhotic cardiomyopathy (CCM) (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Time to acute decompensation event at 1 year. Started Jun 2025; status: recruiting.
02
Drugs
simvastatin
03
Conditions
cirrhotic cardiomyopathy (CCM)
Beyond the preview
Go deeper on NCT06431919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06431919.